RTP Mobile Logo
Visiting Professors Breast Cancer, Issue 1, 2014
Released July 2014

Featuring Drs Beth Overmoyer and Adam M Brufsky’s perspectives on their time spent visiting with patients with breast cancer in the clinics of community oncologists. (Text and Audio Content)

CE Disclosures and Faculty Information

  • OVERVIEW OF ACTIVITY
    Individualized treatment decisions for patients with early, locally advanced or metastatic breast cancer are driven by disease- and patient-specific characteristics. The numerous therapeutic agents and regimens with significant activity in the management of breast cancer provide ample opportunity to deliver tailored care. However, the multiplicity of alternatives may also yield clinical scenarios in which several acceptable treatment options are available, with the optimal strategy being highly debatable and dependent on a thorough understanding of each agent’s unique benefits and risks.

    To provide clinicians with therapeutic strategies to address the disparate needs of patients with breast cancer, the Visiting Professors audio series employs an innovative case-based approach that unites the perspectives of leading breast cancer investigators and general oncologists as they explore the intricacies of making treatment decisions. Upon completion of this CME activity, medical oncologists should be able to formulate an up-to-date and more complete approach to the care of patients with breast cancer.

    LEARNING OBJECTIVES

    • Apply case-based learning, innovative communication strategies and shared clinical insight to provide comprehensive and compassionate oncology care.
    • Effectively integrate biologic, hormonal and cytotoxic therapy into the multifaceted management of metastatic breast cancer.
    • Develop evidence-based treatment approaches for patients diagnosed with HER2-positive breast cancer in the neoadjuvant, adjuvant and metastatic settings.
    • Formulate individualized approaches to later-line therapy for patients with metastatic HER2-negative or triple-negative breast cancer.
    • Evaluate recently presented data supporting the use of extended adjuvant endocrine therapy in pre- and postmenopausal women with hormone-dependent breast cancer and, where appropriate, integrate these findings into clinical practice.
    • Counsel appropriately selected patients with breast cancer about participation in ongoing clinical trials.

    ACCREDITATION STATEMENT
    Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    CME credit is no longer available for this issue

    CREDIT DESIGNATION STATEMENT

    CME credit is no longer available for this issue

    HOW TO USE THIS CME ACTIVITY
    This CME activity contains an audio component. The participant should listen to the audio MP3s.

    CME credit is no longer available for this issue

    CONTENT VALIDATION AND DISCLOSURES
    Research To Practice (RTP) is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent physician reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.

    FACULTY — The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Dr OvermoyerContracted Research: Genentech BioOncology, Incyte Corporation. Dr GuerinSpeakers Bureau: Celgene Corporation, Genomic Health Inc. Dr BrufskyConsulting Agreements: Celgene Corporation, Eisai Inc, Genentech BioOncology, Genomic Health Inc, Novartis Pharmaceuticals Corporation, Roche Laboratories Inc. Dr DeFuscoContracted Research: Genentech BioOncology, Genomic Health Inc, Roche Laboratories Inc.

    EDITOR — Dr Love is president and CEO of Research To Practice, which receives funds in the form of educational grants to develop CME activities from the following commercial interests: AbbVie Inc, Algeta US, Amgen Inc, Astellas, AstraZeneca Pharmaceuticals LP, AVEO Pharmaceuticals, Bayer HealthCare Pharmaceuticals, Biodesix Inc, Biogen Idec, Boehringer Ingelheim Pharmaceuticals Inc, Bristol-Myers Squibb Company, Celgene Corporation, Daiichi Sankyo Inc, Dendreon Corporation, Eisai Inc, Exelixis Inc, Genentech BioOncology, Genomic Health Inc, Gilead Sciences Inc, Incyte Corporation, Lilly, Medivation Inc, Merck, Millennium: The Takeda Oncology Company, Novartis Pharmaceuticals Corporation, Novocure, Onyx Pharmaceuticals Inc, Prometheus Laboratories Inc, Regeneron Pharmaceuticals, Sanofi, Seattle Genetics, Spectrum Pharmaceuticals Inc, Teva Oncology and VisionGate Inc.

    RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose.

    This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantors.

    This activity is supported by educational grants from Eisai Inc and Genentech BioOncology.

    Hardware/Software Requirements:
    An Internet connection that is at least 28.8 Kbps
    A monitor set to 1280 x 1024 pixels or more
    Internet Explorer 6.x or newer, Firefox 2.x or newer, or Safari 2.x or newer
    Macromedia Flash plug-in 6.0 or greater
    Adobe Acrobat Reader (Optional)
    Sound card and speakers for audio

    Release date: July 2014
    Expiration date: July 2015

Acknowledge and close

Listen to audio:
Visiting Professors Breast Cancer, Issue 1, 2014
Released July 2014

Featuring Drs Beth Overmoyer and Adam M Brufsky’s perspectives on their time spent visiting with patients with breast cancer in the clinics of community oncologists. (Text and Audio Content)

Read print: